Hypoxia inducible factor‐1 activator munc‐18‐interacting protein 3 promotes tumour progression in urothelial carcinoma

Hypoxia inducible factor‐1 activator munc‐18‐interacting protein 3 promotes tumour progression in urothelial carcinoma

Abstract Background Although the introduction of multiple agents targeting immune and oncogenic signaling pathways has substantially changed the treatment strategies for urothelial carcinoma (UC), these drugs still have some limitations, such as adverse effects and limited responses depending on the...

Full description

Bibliographic Details
Main Authors: Junichi Ikeda, Chisato Ohe, Noritaka Tanaka, Takashi Yoshida, Ryoichi Saito, Naho Atsumi, Takashi Kobayashi, Hidefumi Kinoshita, Koji Tsuta, Takeharu Sakamoto
Format: Article
Language:English
Published: Wiley 2023-02-01
Series:Clinical and Translational Discovery
Subjects:
Bladder cancer
HIF‐1
Mint3
tissue microarray
urothelial carcinoma
Online Access:https://doi.org/10.1002/ctd2.158

Internet

https://doi.org/10.1002/ctd2.158

Similar Items